Bio-Techne Corporation reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was USD 272.6 million compared to USD 271.58 million a year ago. Net income was USD 27.47 million compared to USD 50.01 million a year ago. Basic earnings per share from continuing operations was USD 0.17 compared to USD 0.32 a year ago. Diluted earnings per share from continuing operations was USD 0.17 compared to USD 0.31 a year ago.
For the six months, sales was USD 549.53 million compared to USD 541.24 million a year ago. Net income was USD 78.46 million compared to USD 139.56 million a year ago. Basic earnings per share from continuing operations was USD 0.5 compared to USD 0.89 a year ago. Diluted earnings per share from continuing operations was USD 0.49 compared to USD 0.86 a year ago.